Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Makito Miyake, Takuya Owari, Shunta Hori, Yasushi Nakai & Kiyohide Fujimoto. (2018) Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma. Research and Reports in Urology 10, pages 251-261.
Read now
Read now
L. Daniel Maxim & Mark J. Utell. (2018) Review of refractory ceramic fiber (RCF) toxicity, epidemiology and occupational exposure. Inhalation Toxicology 30:2, pages 49-71.
Read now
Read now
Grace LeMasters, James E. Lockey, Timothy J. Hilbert, Linda S. Levin, Jeff W. Burkle, Ralph Shipley, Charles Perme, Cristopher A. Meyer & Carol H. Rice. (2017) A 30-year mortality and respiratory morbidity study of refractory ceramic fiber workers. Inhalation Toxicology 29:10, pages 462-470.
Read now
Read now
Eugen Krech, Silvia Selinski, Meinolf Blaszkewicz, Hannah Bürger, Thura Kadhum, Jan G. Hengstler, Michael C. Truss & Klaus Golka. (2017) Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany. Journal of Toxicology and Environmental Health, Part A 80:7-8, pages 430-438.
Read now
Read now
Julia Isermann, Hans-Martin Prager, Rainer Ebbinghaus, Beata Janasik, Wojciech Wasowicz, Bertinus Dufaux, Hans-Friedrich Meyer, Agata Widera, Silvia Selinski, Jan G. Hengstler & Klaus Golka. (2017) Urinary cadmium levels in active and retired coal miners. Journal of Toxicology and Environmental Health, Part A 80:7-8, pages 405-410.
Read now
Read now
Silvia Selinski, Hannah Bürger, Meinolf Blaszkewicz, Thomas Otto, Frank Volkert, Oliver Moormann, Hartmut Niedner, Jan G. Hengstler & Klaus Golka. (2016) Occupational risk factors for relapse-free survival in bladder cancer patients. Journal of Toxicology and Environmental Health, Part A 79:22-23, pages 1136-1143.
Read now
Read now
Luis D. Boada, Luis A. Henríquez-Hernández, Patricio Navarro, Manuel Zumbado, Maira Almeida-González, María Camacho, Eva E. Álvarez-León, Jorge A. Valencia-Santana & Octavio P. Luzardo. (2015) Exposure to polycyclic aromatic hydrocarbons (PAHs) and bladder cancer: evaluation from a gene-environment perspective in a hospital-based case-control study in the Canary Islands (Spain). International Journal of Occupational and Environmental Health 21:1, pages 23-30.
Read now
Read now
Bassel G Bachir & Wassim Kassouf. (2012) Cause–effect? Understanding the risk factors associated with bladder cancer. Expert Review of Anticancer Therapy 12:12, pages 1499-1502.
Read now
Read now
Anna Zimmermann, Rainer Ebbinghaus, Hans-Martin Prager, Meinolf Blaszkewicz, Jan
G. Hengstler & Klaus Golka. (2012) Miners Compensated for Pneumoconiosis and Glutathione S-Transferases M1 and T1 Genotypes. Journal of Toxicology and Environmental Health, Part A 75:8-10, pages 582-587.
Read now
Read now
Klaus Golka, Silke Kopps, Hans-Martin Prager, Stephan
v. Mende, Ralf Thiel, Olaf Jungmann, Jürgen Zumbe, Hermann
M. Bolt, Meinolf Blaszkewicz, Jan
G. Hengstler & Silvia Selinski. (2012) Bladder Cancer in Crack Testers Applying Azo Dye-Based Sprays to Metal Bodies. Journal of Toxicology and Environmental Health, Part A 75:8-10, pages 566-571.
Read now
Read now
Daniel Ovsiannikov, Silvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, Oliver Moormann, Matthias
W. Haenel, Jan
G. Hengstler & Klaus Golka. (2012) Polymorphic Enzymes, Urinary Bladder Cancer Risk, and Structural Change in the Local Industry. Journal of Toxicology and Environmental Health, Part A 75:8-10, pages 557-565.
Read now
Read now
Articles from other publishers (69)
Željka Babić, Sarah Hallmann, Martin S Havmose, Jeanne D Johansen, Swen M John, Cara Symanzik, Wolfgang Uter, Patricia Weinert, Henk F van der Molen, Sanja Kezic, Jelena Macan & Rajka Turk. (2023) Genotoxicity of oxidative hair dye precursors: A systematic review. Human & Experimental Toxicology 42, pages 096032712311598.
Crossref
Crossref
Ya Ling, Jindong Li & Lijuan Zhou. (2023) Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer. International Journal of Immunopathology and Pharmacology 37, pages 039463202311667.
Crossref
Crossref
Jiawei Zhou, Caitao Dong, Jing Tan, Guijun Wang, Zhen Li, Sheng Li & Ziqi He. (2023) Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways. Apoptosis.
Crossref
Crossref
Jae Yoon Kim, Jin-Ha Yoon, Ki-Bong Yoo, Woo-Ri Lee, Wanhyung Lee & Mo-Yeol Kang. (2023) Disparity of Bladder Cancer Incidence Among Male Workers Across Industries. Journal of Occupational & Environmental Medicine 65:9, pages 789-793.
Crossref
Crossref
Bayan Hosseini, Kazem Zendehdel, Liacine Bouaoun, Amy L. Hall, Hamideh Rashidian, Maryam Hadji, Mahin Gholipour, Ali Akbar Haghdoost, Joachim Schüz & Ann Olsson. (2023) Bladder cancer risk in relation to occupations held in a nationwide case‐control study in Iran. International Journal of Cancer 153:4, pages 765-774.
Crossref
Crossref
Klaus Golka, Ralf Böthig, Wobbeke Weistenhöfer, Olaf P. Jungmann, Steffi Bergmann, Michael Zellner & Wolfgang Schöps. (2023) Berufsbedingte Krebserkrankungen in der Urologie – aktuelle Erkenntnisse unter Einbeziehung umweltmedizinischer AspekteOccupation-related cancer in urology—Current knowledge including environmental medical aspects. Journal für Urologie und Urogynäkologie/Österreich 30:2, pages 50-59.
Crossref
Crossref
Lazaros Tzelves, Stamatis Katsimperis, Themistoklis Bellos, Marinos Berdempes, Iraklis Mitsogiannis, Athanasios Papatsoris, Charalampos Deliveliotis, Ioannis Varkarakis & Andreas Skolarikos. (2023) Anthropometric characteristics and relationship with non-muscle invasive bladder cancer in Greece: A case-control study. Archivio Italiano di Urologia e Andrologia.
Crossref
Crossref
Klaus Golka, Ralf Böthig, Wobbeke Weistenhöfer, Olaf P. Jungmann, Steffi Bergmann, Michael Zellner & Wolfgang Schöps. (2022) Berufsbedingte Krebserkrankungen in der Urologie – aktuelle Erkenntnisse unter Einbeziehung umweltmedizinischer AspekteOccupation-related cancer in urology—Current knowledge including environmental medical aspects. Die Urologie 61:11, pages 1198-1207.
Crossref
Crossref
Hiroko Miyagi, Elizabeth A. Di Valerio, Padraic O’Malley, Wayne G. Brisbane, Li-Ming Su & Paul L. Crispen. (2022) Predicting and Decreasing Bladder Tumor Recurrence Following Nephroureterectomy. Frontiers in Urology 2.
Crossref
Crossref
Željka Babić, Marija Macan, Zrinka Franić, Sarah Hallmann, Martin S. Havmose, Jeanne D. Johansen, Swen M. John, Cara Symanzik, Wolfgang Uter, Patricia Weinert, Henk F. van der Molen, Sanja Kezic, Rajka Turk & Jelena Macan. (2022) Association of hairdressing with cancer and reproductive diseases: A systematic review. Journal of Occupational Health 64:1.
Crossref
Crossref
Chien-Cheng Lai, Tzu-Ju Chen, Ti-Chun Chan, Wan-Shan Li & Hong-Lin He. (2021)
Prognostic significance of
OXR1
in urothelial carcinoma: low
OXR1
expression is associated with worse survival
. Future Oncology 17:31, pages 4145-4156.
Crossref
Crossref
Chia‐Wen Tsai, Wen‐Shin Chang, Yifan Xu, Maosheng Huang, Da‐Tian Bau & Jian Gu. (2021) Associations of genetically predicted circulating insulin‐like growth factor‐1 and insulin‐like growth factor binding protein‐3 with bladder cancer risk. Molecular Carcinogenesis 60:11, pages 726-733.
Crossref
Crossref
Klaus Golka, Ralf Böthig, Olaf Jungmann, Martin Forchert, Michael Zellner & Wolfgang Schöps. (2021) Berufsbedingte Krebserkrankungen in der UrologieOccupational cancers in urology. Der Urologe 60:8, pages 1061-1072.
Crossref
Crossref
Meng Chen, Yifan Xu, Junfeng Xu, Haidee Chancoco & Jian Gu. (2021) Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case–Control Study and Mendelian Randomization Analysis. Cancer Epidemiology, Biomarkers & Prevention 30:1, pages 203-209.
Crossref
Crossref
Eduardo Alarcón-Capel, Alberto Ruano-Ravina & Juan M. Barros-Dios. (2021) Exposición al radón y cáncer genitourinario en mineros. Gaceta Sanitaria 35:1, pages 72-80.
Crossref
Crossref
Shawn Dason & Nathan C. Wong. 2021. Comprehensive Diagnostic Approach to Bladder Cancer. Comprehensive Diagnostic Approach to Bladder Cancer
13
44
.
. 2020. Diet and Fighting Bladder Cancer. Diet and Fighting Bladder Cancer
109
115
.
John Havens Cary & Howard I. Maibach. 2020. Kanerva’s Occupational Dermatology. Kanerva’s Occupational Dermatology
1867
1877
.
Manolis Kogevinas. 2020. Occupational Cancers. Occupational Cancers
487
506
.
Salim K. Cheriyan, Charles C. Peyton, Evan M. Holsonback, Mounsif Azizi & Philippe E. Spiess. 2020. Cancer Regional Therapy. Cancer Regional Therapy
413
425
.
A. Hartwig. 2002. The MAK‐Collection for Occupational Health and Safety. The MAK‐Collection for Occupational Health and Safety
2168
2273
.
Wentao Zhang, Shiyu Mao, Donghui Shi, Junfeng Zhang, Ziwei Zhang, Yadong Guo, Yuan Wu, Ruiliang Wang, Longsheng Wang, Yong Huang & Xudong Yao. (2019) MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1. Frontiers in Oncology 9.
Crossref
Crossref
Timothy Hua-Tse Cheng, Wayne Lam & Jeremy Yuen-Chun Teoh. 2019. Urologic Oncology. Urologic Oncology
3
17
.
Sarah P. Psutka & Sima Porten. (2018) Unraveling Associations Between Occupation and Bladder Cancer Aggressiveness: Describing the Landscape. European Urology Focus 4:5, pages 731-732.
Crossref
Crossref
. 2018. Urologische Tumoren. Urologische Tumoren
243
282
.
Timothy Hua-Tse Cheng, Wayne Lam & Jeremy Yuen-Chun Teoh. 2018. Urologic Oncology. Urologic Oncology
1
15
.
John Havens Cary & Howard I. Maibach. 2018. Kanerva’s Occupational Dermatology. Kanerva’s Occupational Dermatology
1
11
.
Fatemeh Farzaneh, Amir Houshang Mehrparvar & Mohammad Hasan Lotfi. (2017) Occupations and the Risk of Bladder Cancer in Yazd Province: A Case-Control Study. The International Journal of Occupational and Environmental Medicine 8:4, pages 191-198.
Crossref
Crossref
Jun Miyazaki & Hiroyuki Nishiyama. (2017) Epidemiology of urothelial carcinoma. International Journal of Urology 24:10, pages 730-734.
Crossref
Crossref
Xiyi Jiang, Shaofang Cai, Yunqing Hu, Ding Ye, Qilong Li, Kun Chen & Mingjuan Jin. (2017) Sex disparities in cancer incidence in Jiashan County, China, 1995–2014. Cancer Epidemiology 50, pages 46-52.
Crossref
Crossref
A. Hartwig. 2002. The MAK‐Collection for Occupational Health and Safety. The MAK‐Collection for Occupational Health and Safety
878
985
.
Hussain Gadelkarim Ahmed, Fawaz D Alshmmari, Ibrahim Abdelmajeed Ginawi, Nasser Gazi Alshammari, Abdullah Mohammed Abdullah Alshammari, Mohammed Ahmed Alshuqayr & Mohammed Turki Alkhariji. (2017) Assessment of urothelial cells atypical changes among petroleum station workers in Saudi Arabia. European Journal of Inflammation 15:1, pages 1-7.
Crossref
Crossref
Mathilde Boulanger, Séverine Tual, Clémentine Lemarchand, Anne-Valérie Guizard, Michel Velten, Elisabeth Marcotullio, Isabelle Baldi, Bénédicte Clin & Pierre Lebailly. (2016) Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort. International Archives of Occupational and Environmental Health 90:2, pages 169-178.
Crossref
Crossref
Marcus G. Cumberbatch, Ben Windsor-Shellard & James W. F. Catto. (2017) The contemporary landscape of occupational bladder cancer within the United Kingdom: a meta-analysis of risks over the last 80 years. BJU International 119:1, pages 100-109.
Crossref
Crossref
Ricardo Contreras-García & Herney Andrés García-Perdomo. (2016) Diagnóstico, evaluación y seguimiento de la hematuria microscópica. Un enfoque al alcance de todos. Urología Colombiana 25:3, pages 231-238.
Crossref
Crossref
Abdulmohsen H. Al-Zalabani, Kelly F. J. Stewart, Anke Wesselius, Annemie M. W. J. Schols & Maurice P. Zeegers. (2016) Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. European Journal of Epidemiology 31:9, pages 811-851.
Crossref
Crossref
Meng Chen, Nathaniel Rothman, Yuanqing Ye, Jian Gu, Paul A. Scheet, Maosheng Huang, David W. Chang, Colin P. Dinney, Debra T. Silverman, Jonine D. Figueroa, Stephen J. Chanock & Xifeng Wu. (2016) Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development. Genes & Cancer 7:7-8, pages 229-239.
Crossref
Crossref
Kishor Hadkhale, Jan Ivar Martinsen, Elisabete Weiderpass, Kristina Kjaerheim, Elsebeth Lynge, Pär Sparen, Laufey Tryggvadottir & Eero Pukkala. (2016) Occupation and Risk of Bladder Cancer in Nordic Countries. Journal of Occupational & Environmental Medicine 58:8, pages e301-e307.
Crossref
Crossref
Jakub Dobruch, Siamak Daneshmand, Margit Fisch, Yair Lotan, Aidan P. Noon, Matthew J. Resnick, Shahrokh F. Shariat, Alexandre R. Zlotta & Stephen A. Boorjian. (2016) Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. European Urology 69:2, pages 300-310.
Crossref
Crossref
Lidija Latifovic, Paul J. Villeneuve, Marie‐Élise Parent, Kenneth C. Johnson, Linda Kachuri & Shelley A. Harris. (2015) Bladder cancer and occupational exposure to diesel and gasoline engine emissions among Canadian men. Cancer Medicine 4:12, pages 1948-1962.
Crossref
Crossref
Núria Malats & Francisco X. Real. (2015) Epidemiology of Bladder Cancer. Hematology/Oncology Clinics of North America 29:2, pages 177-189.
Crossref
Crossref
Bulent Erol, Ismail Ulus, Yavuz Onur Danacıoglu & Turhan Çaşkurlu. (2015) Bladder Cancer and Genetic Polymorphisms: A Review. EMJ Urology, pages 20-25.
Crossref
Crossref
S. Medani, P. O'Kelly, K.M. O'Brien, P. Mohan, C. Magee & P. Conlon. (2014) Bladder Cancer in Renal Allograft Recipients: Risk Factors and Outcomes. Transplantation Proceedings 46:10, pages 3466-3473.
Crossref
Crossref
Ronac Mamtani, Nick Pfanzelter, Kevin Haynes, Brian S. Finkelman, Xingmei Wang, Stephen M. Keefe, Naomi B. Haas, David J. Vaughn & James D. Lewis. (2014) Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. Diabetes Care 37:7, pages 1910-1917.
Crossref
Crossref
Jelle Vlaanderen, Kurt Straif, Avima Ruder, Aaron Blair, Johnni Hansen, Elsebeth Lynge, Barbara Charbotel, Dana Loomis, Timo Kauppinen, Pentti Kyyronen, Eero Pukkala, Elisabete Weiderpass & Neela Guha. (2014) Tetrachloroethylene Exposure and Bladder Cancer Risk: A Meta-Analysis of Dry-Cleaning-Worker Studies. Environmental Health Perspectives 122:7, pages 661-666.
Crossref
Crossref
Ryan W. Dobbs, Lee A. Hugar, Louis M. Revenig, Usama Al-Qassab, John A. Petros, Chad W. Ritenour, Muta M. Issa & Daniel J. Canter. (2014) Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer. International braz j urol 40:2, pages 198-203.
Crossref
Crossref
MF EylertLS HounsomeRA PersadA BahlER JefferiesJ VerneH Mostafid. (2016) Falling bladder cancer incidence from 1990 to 2009 is not producing universal mortality improvements. Journal of Clinical Urology 7:2, pages 90-98.
Crossref
Crossref
Delia Cavallo, Valentina Casadio, Sara Bravaccini, Sergio Iavicoli, Enrico Pira, Canzio Romano, Anna Maria Fresegna, Raffaele Maiello, Aureliano Ciervo, Giuliana Buresti, Wainer Zoli & Daniele Calistri. (2014) Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry. BioMed Research International 2014, pages 1-8.
Crossref
Crossref
J. Ferrís, J. Garcia, O. Berbel & J.A. Ortega. (2013) Constitutional and occupational risk factors associated with bladder cancer. Actas Urológicas Españolas (English Edition) 37:8, pages 513-522.
Crossref
Crossref
J. Ferrís, J. Garcia, O. Berbel & J.A. Ortega. (2013) Factores de riesgo constitucionales y ocupacionales asociados al cáncer vesical. Actas Urológicas Españolas 37:8, pages 513-522.
Crossref
Crossref
Richard T. Bryan, Maurice P. Zeegers, Eline H. van Roekel, Deborah Bird, Margaret R. Grant, Janet A. Dunn, Sarah Bathers, Gulnaz Iqbal, Humera S. Khan, Stuart I. Collins, Andrew Howman, Nayneeta S. Deshmukh, Nicholas D. James, Kar Keung Cheng & D. Michael A. Wallace. (2013)
A comparison of patient and tumour characteristics in two
UK
bladder cancer cohorts separated by 20 years
. BJU International 112:2, pages 169-175.
Crossref
Crossref
Firas Abdollah, Giorgio Gandaglia, Rodolphe Thuret, Jan Schmitges, Zhe Tian, Claudio Jeldres, Niccolò Maria Passoni, Alberto Briganti, Shahrokh F. Shariat, Paul Perrotte, Francesco Montorsi, Pierre I. Karakiewicz & Maxine Sun. (2013) Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis. Cancer Epidemiology 37:3, pages 219-225.
Crossref
Crossref
Holger Schwender, Silvia Selinski, Meinolf Blaszkewicz, Rosemarie Marchan, Katja Ickstadt, Klaus Golka & Jan G. Hengstler. (2012) Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers. PLoS ONE 7:12, pages e51880.
Crossref
Crossref
Jong-Wei Hsu & Michael King. (2012) Applications of Nanotechnology in Bladder Cancer Therapy. Journal of Healthcare Engineering 3:4, pages 535-550.
Crossref
Crossref
Ronac Mamtani, Kevin Haynes, Warren B. Bilker, David J. Vaughn, Brian L. Strom, Karen Glanz & James D. Lewis. (2012) Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study. JNCI: Journal of the National Cancer Institute 104:18, pages 1411-1421.
Crossref
Crossref
Ewa Dudziec & James W. F. Catto. 2012. Epigenomics. Epigenomics
323
337
.
Glenn Talaska, Beverly Gaultney, Susan Peters, Paul Succop & Roel Vermeulen. (2012) 2-Naphthol levels and genotoxicity in rubber workers. Toxicology Letters 213:1, pages 45-48.
Crossref
Crossref
D.Y. Zhong, H.Y. Chu, M.L. Wang, L. Ma, D.N. Shi & Z.D. Zhang. (2012) Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk. Genetics and Molecular Research 11:3, pages 3490-3496.
Crossref
Crossref
David P. WoodJr.Jr.. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
2309
2334.e6
.
Patricia G. Engasser, Howard I. Maibach, Tam Tiet & James S. Taylor. 2012. Kanerva's Occupational Dermatology. Kanerva's Occupational Dermatology
1381
1388
.
Jian Gu & Xifeng Wu. (2011) Genetic susceptibility to bladder cancer risk and outcome. Personalized Medicine 8:3, pages 365-374.
Crossref
Crossref
. (2012) Schilders hebben groter risico op blaaskanker. Tijdschrift voor bedrijfs- en verzekeringsgeneeskunde 19:2, pages 84-85.
Crossref
Crossref
Maria J. Ribal. 2011. Bladder Tumors:. Bladder Tumors:
1
22
.
Sean R. Williamson, Rodolfo Montironi, Antonio Lopez-Beltran, Gregory T. MacLennan, Darrell D. Davidson & Liang Cheng. (2010) Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: The state of the art. Critical Reviews in Oncology/Hematology 76:2, pages 112-126.
Crossref
Crossref
C Giberti, F Gallo, M Schenone & A Genova. (2010) Early Results of Urothelial Carcinoma Screening in a Risk Population of Coke Workers: Urothelial Carcinoma among Coke Workers. Biomedical and Environmental Sciences 23:4, pages 300-304.
Crossref
Crossref
Sharif B. Mohr, Cedric F. Garland, Edward D. Gorham, William B. Grant & Frank C. Garland. (2010) Ultraviolet B Irradiance and Incidence Rates of Bladder Cancer in 174 Countries. American Journal of Preventive Medicine 38:3, pages 296-302.
Crossref
Crossref
Adrian Cassidy, Wei Wang, Xifeng Wu & Jie Lin. (2009) Risk of urinary bladder cancer: a case-control analysis of industry and occupation. BMC Cancer 9:1.
Crossref
Crossref
Marko Babjuk. (2009) The Search for the Etiology of Bladder Cancer: Are Achievements Sufficient?. European Urology 56:5, pages 771-772.
Crossref
Crossref
Gonzalo Lopez-Abente, Olivier Nuuez, Beatriz Perez-Gomez, Nuria Aragones & Marina Pollan. (2015) La Situaciin Del CCncer En Espaaa: Informe 2015 (The Situation of Cancer in Spain: Report 2015). SSRN Electronic Journal.
Crossref
Crossref